Authors: DAHLEN B NIZANKOWSKA E SZCZEKLIK A ZETTERSTROM O BOCHENEK G KUMLIN M MASTALERZ L PINIS G SWANSON LJ BOODHOO TI WRIGHT S DUBE LM DAHLEN SE

Citation: B. Dahlen et al., BENEFITS FROM ADDING THE 5-LIPOXYGENASE INHIBITOR ZILEUTON TO CONVENTIONAL THERAPY IN ASPIRIN-INTOLERANT ASTHMATICS, American journal of respiratory and critical care medicine, 157(4), 1998, pp. 1187-1194

Authors: DEKKER JW NIZANKOWSKA E SCHMITZSCHUMANN M PILE K BOCHENEK G DYCZEK A COOKSON WOCM SZCZEKLIK A

Citation: Jw. Dekker et al., ASPIRIN-INDUCED ASTHMA AND HLA-DRB1 AND HLA-DPB1 GENOTYPES, Clinical and experimental allergy, 27(5), 1997, pp. 574-577

Authors: BOCHENEK G NIZANKOWSKA E SZCZEKLIK A

Citation: G. Bochenek et al., THE ATOPY TRAIT IN HYPERSENSITIVITY TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Allergy, 51(1), 1996, pp. 16-23

Authors: NIZANKOWSKA E SOJA J PINIS G BOCHENEK G SLADEK K DOMAGALA B PAJAK A SZCZEKLIK A

Citation: E. Nizankowska et al., TREATMENT OF STEROID-DEPENDENT BRONCHIAL-ASTHMA WITH CYCLOSPORINE, The European respiratory journal, 8(7), 1995, pp. 1091-1099

Authors: NIZANKOWSKA E SOJA J PINIS G BOCHENEK G SLADEK K DOMAGALA B PAJAK A SZCZEKLIK A

Citation: E. Nizankowska et al., TREATMENT OF STEROID-DEPENDENT ASTHMA WITH CYCLOSPORINE (CYA), The American review of respiratory disease, 147(4), 1993, pp. 294-294